FDA – Page 73 – Pharma.Tips

Distribution temperature breach during distribution qualification – how to prevent repeat excursions

Investigating Distribution Temperature Breaches During Qualification to Prevent Future Excursions Distribution temperature breaches during distribution qualification pose substantial risks in pharmaceutical operations. Such excursions can lead to product degradation, compliance…

System access control failure during system operation – preventing repeat CSV observations

Addressing System Access Control Failures During Operations: An Investigation Framework Pharmaceutical manufacturing environments rely heavily on information technology systems to support operational integrity and data quality. A failure in system…

Transport qualification gaps during transportation – regulatory inspection outcome

Investigation into Transport Qualification Gaps During Transportation: Ensuring Regulatory Compliance Transport qualification gaps during transportation pose significant risks for pharmaceutical manufacturers, potentially leading to compliance issues, product integrity failures, and…

CSV not aligned to actual use during inspection walkthrough – preventing repeat CSV observations

Investigating CSV Misalignment to Actual Use in Pharma Operations In the stringent landscape of pharmaceutical manufacturing, maintaining compliance with regulatory requirements is critical—especially during inspections. A common issue that arises…

Distribution temperature breach during distribution qualification – regulatory inspection outcome

Understanding the Impact of Distribution Temperature Breaches During Qualification: An Investigation for Compliance In the highly regulated pharmaceutical industry, maintaining strict temperature control during distribution qualification is paramount. A breach…

System access control failure during validation lifecycle – data integrity risk and remediation

Understanding System Access Control Failures During the Validation Lifecycle and Their Remediation In the pharmaceutical manufacturing environment, ensuring robust system access control throughout the validation lifecycle is paramount in maintaining…

Cold chain excursion not assessed during audit – documentation pack for auditors

Addressing Cold Chain Excursions During Audits: A Comprehensive Investigation Guide Cold chain excursions pose significant challenges in pharmaceutical operations, especially in maintaining product integrity and regulatory compliance. When such excursions…

User account governance failures during inspection walkthrough – data integrity risk and remediation

User Account Governance Failures: Addressing Data Integrity Risks during Inspections The pharmaceutical sector faces increasing scrutiny regarding data integrity, particularly during regulatory inspection walkthroughs. A common issue arising from inadequate…

Transport qualification gaps during transportation – CAPA and system remediation

Identifying and Addressing Gaps in Transport Qualification During Pharmaceutical Transportation The transportation of pharmaceutical products is a critical process that can significantly impact product quality and regulatory compliance. Transport qualification…

Tag: FDA